Adriann Sax

Adriann Sax

Founder at
Vetigenics LLC
65 year
Health Technology
Consumer Services
Commercial Services

Profile

Adriann W.
Sax
is the founder of Vetigenics LLC, serving as President, Chief Executive Officer & Director since 2017.
Former positions include Chief Executive Officer & Director at Orsenix LLC from 2019 to 2020, Executive Director-Oncology at Merck & Co., Inc., Director at Healthcare Businesswomen Association, Independent Director at QSAM Biosciences, Inc. from 2022 to 2024, Vice President-Marketing at Bristol Myers Squibb Co., EVP-Business Development & Strategic Planning at KP Pharmaceuticals LLC, Principal at Sterling Drug, Inc., Chief Business Officer at Symphogen A, Principal at Roche Laboratories, Inc., and Chief Commercial Officer & Executive VP at Kadmon Corp.
LLC.
Education includes an undergraduate degree from the University of Delaware and an MBA from Keller Graduate School of Management.

Adriann Sax active positions

CompaniesPositionStart
Founder 31/12/2016

Former positions of Adriann Sax

CompaniesPositionEnd
Director/Board Member 01/05/2024
Chief Executive Officer 31/12/2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
See the detail of Adriann Sax's experience

Training of Adriann Sax

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

9

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Non-Durables

Consumer Services

Health Technology

Distribution Services

Consumer Services

Health Technology

Process Industries

Health Technology

Health Technology